NO955067D0 - FVII/TF peptider - Google Patents

FVII/TF peptider

Info

Publication number
NO955067D0
NO955067D0 NO955067A NO955067A NO955067D0 NO 955067 D0 NO955067 D0 NO 955067D0 NO 955067 A NO955067 A NO 955067A NO 955067 A NO955067 A NO 955067A NO 955067 D0 NO955067 D0 NO 955067D0
Authority
NO
Norway
Prior art keywords
pct
date
sec
fvii
peptides
Prior art date
Application number
NO955067A
Other languages
English (en)
Norwegian (no)
Other versions
NO955067L (no
Inventor
Ross W Stephens
Lars Orning
Kjell Steinar Sakariassen
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939312601A external-priority patent/GB9312601D0/en
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of NO955067D0 publication Critical patent/NO955067D0/no
Publication of NO955067L publication Critical patent/NO955067L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO955067A 1993-06-18 1995-12-14 FVII/TF peptider NO955067L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939312601A GB9312601D0 (en) 1993-06-18 1993-06-18 Peptides
GB9409335A GB9409335D0 (en) 1993-06-18 1994-05-10 Peptides
PCT/GB1994/001315 WO1995000541A1 (fr) 1993-06-18 1994-06-17 Peptides derives du facteur vii

Publications (2)

Publication Number Publication Date
NO955067D0 true NO955067D0 (no) 1995-12-14
NO955067L NO955067L (no) 1995-12-14

Family

ID=26303086

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955067A NO955067L (no) 1993-06-18 1995-12-14 FVII/TF peptider

Country Status (15)

Country Link
US (1) US5962418A (fr)
EP (1) EP0703923B1 (fr)
JP (1) JPH08511794A (fr)
CN (1) CN1125450A (fr)
AT (1) ATE171950T1 (fr)
CA (1) CA2164422A1 (fr)
CZ (1) CZ334095A3 (fr)
DE (1) DE69413817T2 (fr)
DK (1) DK0703923T3 (fr)
FI (1) FI956055L (fr)
HU (1) HUT74873A (fr)
NO (1) NO955067L (fr)
NZ (1) NZ267453A (fr)
SK (1) SK156395A3 (fr)
WO (1) WO1995000541A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
GB9425381D0 (en) * 1994-12-15 1995-02-15 Nycomed Pharma As Peptides
GB9425380D0 (en) * 1994-12-15 1995-02-15 Nycomed Pharma As Peptides
US5837684A (en) * 1995-06-07 1998-11-17 Nycomed Imaging As Peptides
WO1999013063A1 (fr) * 1997-09-09 1999-03-18 Nycomed Imaging As Fragments du facteur vii et leurs analogues, utilisation dans le traitement des troubles dus aux caillots sanguins
WO1999013062A1 (fr) * 1997-09-09 1999-03-18 Nycomed Imaging As Fragments de facteur vii, leurs analogues, et leur utilisation dans le traitement de troubles lies a la coagulation du sang
EP0987274A1 (fr) 1998-09-15 2000-03-22 Hoechst Marion Roussel Deutschland GmbH Inhibiteurs du facteur VIIa
AU5062100A (en) 1999-06-14 2001-01-02 Novo Nordisk A/S Fviia/tf activity inhibiting compounds
AU781618C (en) 1999-07-02 2006-03-16 Genentech Inc. FVIIa antagonists
US7164002B2 (en) 2002-02-06 2007-01-16 Genentech, Inc. FVIIa antagonists
US20060257359A1 (en) * 2005-02-28 2006-11-16 Cedric Francois Modifying macrophage phenotype for treatment of disease
DK3402537T3 (da) 2016-01-15 2021-03-29 Rigshospitalet Kvantitativ PET-afbildning af vævsfaktorekspression under anvendelse af 18-F mærket, aktiv positions-inhiberet faktor VII
US20190358351A1 (en) 2016-11-17 2019-11-28 Minerva Imaging Aps 177-lu labeled active site inhibited factor vii

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496927A (en) * 1985-02-04 1996-03-05 Merrell Pharmaceuticals Inc. Peptidase inhibitors
US4772587A (en) * 1985-04-16 1988-09-20 Suntory Limited Dipeptide derivative of fatty acid
US5087564A (en) * 1985-06-20 1992-02-11 Monsanto Company Release of recombinant peptides from polypeptides using V8 endopeptidase
US5047401A (en) * 1985-09-09 1991-09-10 Board Of Regents, The University Of Texas System Use of dipeptide alkyl esters to treat GVHD
EP0391999A4 (en) * 1988-09-23 1991-03-13 Corvas, Inc. Peptidyl inhibitors of the initiation of coagulation
JP3330932B2 (ja) * 1990-01-29 2002-10-07 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 抗凝固剤タンパク質
DE4007902A1 (de) * 1990-03-13 1991-09-19 Behringwerke Ag Synthetische peptide, die sequenzen aus faktor viia enthalten und deren verwendung
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
WO1993009804A1 (fr) * 1991-11-18 1993-05-27 The Scripps Research Institute Polypeptides derives de la serine protease et anticorps anti-peptidiques, systemes et procedes therapeutiques empechant la coagulation du sang

Also Published As

Publication number Publication date
EP0703923A1 (fr) 1996-04-03
AU6975594A (en) 1995-01-17
HU9503593D0 (en) 1996-02-28
ATE171950T1 (de) 1998-10-15
NZ267453A (en) 1997-03-24
HUT74873A (en) 1997-02-28
SK156395A3 (en) 1996-06-05
NO955067L (no) 1995-12-14
AU691814B2 (en) 1998-05-28
CZ334095A3 (en) 1996-07-17
US5962418A (en) 1999-10-05
CA2164422A1 (fr) 1995-01-05
JPH08511794A (ja) 1996-12-10
DK0703923T3 (da) 1999-06-21
WO1995000541A1 (fr) 1995-01-05
DE69413817T2 (de) 1999-06-10
FI956055A7 (fi) 1996-01-26
EP0703923B1 (fr) 1998-10-07
CN1125450A (zh) 1996-06-26
DE69413817D1 (de) 1998-11-12
FI956055A0 (fi) 1995-12-15
FI956055L (fi) 1996-01-26

Similar Documents

Publication Publication Date Title
DK0535091T3 (da) Knogleinducerende farmaceutiske formuleringer
HU9503593D0 (en) Factor vii-derived peptides
EA200000652A1 (ru) Кристаллы глюкагоноподобного пептида 1
SE0002202D0 (sv) New peptides
IL129238A0 (en) N-(aryl/heteroarylacetyl) amino acid esters pharmaceutical compositions comprising same and methods for inhibiting b-amyloid peptide release and/ or its synthesis by use of such compounds
BR9607647A (pt) Derivado de insulina e composição farmacêutica e processo para o tratamento de diabetes em um paciente em necessidade deste tratamento
MY135057A (en) Dolastatin 15 derivatives
BG103793A (en) COMBINED THERAPY USING BENZOTHIAPINS INHIBITING THE ILEAL BILE ACID TRANSPORT AND HMG Co-A REDUCTASE INHIBITORS
WO2003068141A3 (fr) Compositions cosmetiques ou dermopharmaceutiques pour diminuer les poches et cernes sous les yeux.
BR9714358A (pt) Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
ATE489462T1 (de) Antimikrobielles polypeptid und nutzung davon
MXPA02000465A (es) Derivados ciclopeptidicos como inhibidores de la integrina alfav beta6.
AU8649101A (en) Integrin binding motif containing peptides and methods of treating skeletal diseases
WO1996028470A3 (fr) Analogues peptidiques de proteine de base de myeline utile dans le traitement de la sclerose en plaques
SG129211A1 (en) Therapeutic molecules
KR910007960A (ko) 항응고성 펩티드
RU97112745A (ru) Варианты апротинина с улучшенными свойствами
HU0102043D0 (en) Pharmaceutical compounds which interact with an ca2+ channel alpha2delta subunit
MXPA02012308A (es) Nuevo interferon para el tratamiento de esclerosis multiple.
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
GB2262528B (en) Further improvements relating to the radiolabelling of proteins
FI942938L (fi) Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
WO2000027374A3 (fr) Utilisation d'inhibiteurs des transporteurs d'acides amines excitateurs pour reduire les lesions de la substance blanche du systeme nerveux central
DE69922150D1 (de) Deoxyhypusin reagenz und peptide

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application